New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
07:34 EDTWBMDWebMD sees Q1 adjusted EBITDA above high end of previous guidance
Sees Q1 revenue to be at the high end of the range previously provided. For the FY14, WebMD expects to be in the top half of the ranges previously provided for revenue, Adjusted EBITDA and net income. "The update to our guidance that we are providing today reflects recent improvements in our sales activity compared to our experience in the early weeks of 2014," said the company. "We are having very positive dialogue with our customers about how WebMD can help address their evolving business needs and we are continuing our investments in new product and service offerings to better serve those needs and realize future growth opportunities."
News For WBMD From The Last 14 Days
Check below for free stories on WBMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
07:04 EDTWBMDWebMD announces preliminary results of tender offer
WebMD Health announced the preliminary results of its tender offer to purchase up to 2,000,000 shares of its common stock at a price of $48.50 per share, which expired at 5:00 p.m., New York City time, on September 9. Based on the preliminary count by American Stock Transfer & Trust Company, the Depositary for the tender offer, approximately 6.3 million shares of common stock were properly tendered and not withdrawn, including: approximately 1.3 million shares that were tendered through notice of guaranteed delivery; and approximately 1.1 million shares that were conditionally tendered by stockholders and for which the determination whether the applicable conditions were met will be made following the verification process described below. Accordingly, WebMD expects to accept for purchase a total of 2,000,000 shares at a purchase price of $48.50 per share, for an aggregate purchase price of $97M. Since the offer was oversubscribed, the number of shares that WebMD will purchase from each tendering shareholder will be pro-rated. Based upon the preliminary count and including all shares conditionally tendered, WebMD estimates that the pro-ration factor would be approximately 31.5%.
September 9, 2014
08:34 EDTWBMDWebMD to benefit from Apple initiatives, says RBC Capital
RBC Capital expects WebMD (WBMD) to benefit from Apple's (AAPL) launch of initiatives in the consumer health IT market. The firm believes that Apple's efforts in this area will provide more publicity for WebMD. RBC Capital keeps a $70 price target and Top Pick rating on WebMD.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use